CRBP
NASDAQ · Biotechnology
Corbus Pharmaceuticals Holdi
$2.75
-0.27 (-8.80%)
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Price Target
Analyst Price Target
+342.6% upside
Low Target
$8.71
Average Target
$12.15
High Target
$17.60
Current Price
$2.75
Current
$2.75
$2.75
Target
$12.15
$12.15
$8.71
$12.15 avg
$17.60
Scenario Analysis
Bear Case
$8.71
217.3%
Low target
Base Case
$12.15
+342.6%
Avg target
Bull Case
$17.60
+541.2%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$12.88
-78.7% from high
52-Week Low
$2.81
+-2.3% from low
Target vs 52W High
$12.15
-5.7% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -9.2% |
| AMGN | Hold | 42 | 43% | $190.87 | -56.5% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +117.8% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -15.8% |
| REGN | Buy | 36 | 72% | $76.80 | -91.7% |
| MRNA | Hold | 31 | 32% | $149.45 | -25.0% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -50.7% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -28.4% |